StockIQ.techQiagen N.V. (QIA.DE) Stock Analysis
Free AI-powered analysis and research for Qiagen N.V. stock
Sector: Healthcare
QIA.DE snapshot
Data as of 4 Nov 2026 close. Updated daily.
Qiagen N.V. scores 94/100 on StockIQ's model, which reads as strongly positive signals overall. The price is above its 200-day average and at 88% of its 52-week range, up 8.3% over the past year. Latest reported figures show a profit margin of 19.5%, return on equity of 11.9% and revenue growth of +0.3%.
What is driving the score
- Strong Uptrend: +12
- MACD Bullish: +8
- Good Profit Margin (19.5%): +5
- Strong Liquidity (2.85 Current Ratio): +8
- Strong Long-term Uptrend: +8
- Up Over 1 Year (+8.3%): +3
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full QIA.DE report
Qiagen N.V. (QIA.DE) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze QIA.DE Now →📰 Latest Update
Why Is Qiagen (QGEN) Down 9.4% Since Last Earnings Report?
Fri, March 6, 2026 at 12:00 PM UTC 3 min read
Qiagen (QGEN) has seen a 9.4% decline in its stock price since its last earnings report, primarily due to weaker-than-expected revenue guidance and concerns over declining demand for COVID-19 testing products. This downturn raises concerns for investors about the company's growth prospects and its ability to maintain profitability in a post-pandemic environment. Investors will be closely monitoring future earnings reports for signs of recovery and strategic adjustments.